Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RELAX-AHF phase III trial of intravenous relaxin in acute heart failure
NL-OMON36636Phase 3Active, not recruiting
- Sponsor
- Corthera, Inc.
- Start
- Feb 2011
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of Relaxin in Acute Heart Failure (AHF), sponsored by Corthera, Inc.. Started Feb 2011; status: active, not recruiting.
02
Drugs
Relaxin
03
Conditions
Acute Heart Failure (AHF)
Beyond the preview
Go deeper on NL-OMON36636.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36636.